Aaron Schuchart

Insider Reports History

Entity
Individual
Location
C/O Aeglea Biotherapeutics, Inc., 901 S.Mopac Expwy,Bartonoaksplazone,#250, Austin, TX
Signature
/s/ Ryan Trytten, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aaron Schuchart:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LUMOS PHARMA, INC. Chief Business Officer Common Stock 0 $0 $1.89 Dec 12, 2024 Direct
LUMOS PHARMA, INC. Chief Business Officer Stock Option (Right to Buy) 0 Dec 12, 2024 Direct

Insider Reports Filed by Aaron Schuchart

Symbol Company Period Transactions Value $ Form Type Date Filed Role
(LUMO) LUMOS PHARMA, INC. Dec 12, 2024 7 $0 4 Dec 13, 2024 Chief Business Officer
(LUMO) LUMOS PHARMA, INC. Apr 1, 2024 2 $2.84K 4 Apr 3, 2024 Chief Business Officer
(LUMO) LUMOS PHARMA, INC. Feb 1, 2024 1 -$608 4 Feb 5, 2024 Chief Business Officer
LUMO LUMOS PHARMA, INC. Feb 1, 2023 3 $3.15K 4 Feb 3, 2023 Chief Business Officer
LUMO LUMOS PHARMA, INC. Feb 1, 2022 3 $9.5K 4 Feb 3, 2022 Chief Business Officer
LUMO LUMOS PHARMA, INC. Aug 11, 2021 2 $14.8K 4 Aug 13, 2021 Chief Business Officer
LUMO LUMOS PHARMA, INC. Jun 1, 2021 1 $0 4 Jun 3, 2021 Chief Business Officer
LUMO LUMOS PHARMA, INC. May 19, 2021 0 $0 3 May 28, 2021 Chief Business Officer